Tumor Myeloid Microenvironment Directed Therapeutics Summit 2021

Temas de la conferencia
With the explosive excitement and clinical proof of concept utilizing CD47 approaches, 2020 is the year for macrophage development, as we witness greater interest and investment in new work on novel macrophage targets outside of CD47.

Tumor Myeloid Microenvironment Directed Therapeutics Summit is focused on optimizing the potential of immunotherapy, through direct modulation of tumor-resident myeloid populations to retune the microenvironment for improved response rates to therapy.

Organizador profesional (PCO)
Hanson Wade

Observaciones
Brochure: https://go.evvnt.com/701752-3?pid=4832

Speakers: Peter Ellmark, Alligator Bioscience AB, Victoria Smith, Amphivena Therapeutics Inc., Kaiming Ye, Binghamton University, Michael Klichinsky, Carisma Therapeutics and more

https://go.evvnt.com/701752-0?pid=4832

Ms. Aarti Diwan